Tag Page Excerpt: These cheap biotech stocks to buy could gain as much as 180% in the next 12 months.
Their rapid stock price gains are largely due to the new drugs these companies are releasing.
INSY
Insys Therapeutics Inc
One of the Best Biotech Stocks in 2017 Could Double Your Money
One of the best biotech stocks in 2017 could double in price in the next 12 months or less.
And that might just be the beginning, depending on how its newest drug performs on the market and how its pipeline treatments perform in ongoing phase 3 clinical trials this year.
Here's what you need to know for maximum profits in 2017...
Insys Therapeutics Stock Gave Us a 26% Return in Just 12 Days... and That's Only the Start
Despite the recent negative news, Insys Therapeutics stock is still a great buy.
Even better for investors is the fact that it has an upcoming catalyst that is going to send the price per share soaring.
How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top Execs
Once again, a Big Pharma company has rewarded its top execs at the expense of shareholders…
Mylan overcharged the government (a.k.a. the taxpayers) for EpiPen distribution by over a billion dollars.
Our "War on Pain" Biotech Put You Up by Double Digits in Just Two Weeks
Insys Therapeutics – our "War on Pain" biotech play – has given us a profit of more than 10.7% since we recommended the stock a little less than two weeks ago.
I hope you like profits, because that's just for starters.
The U.S. Food and Drug Administration (FDA) last week approved the final "product label" for the company's new synthetic marijuana drug – which means Insys can bring this new therapy to market in August.
Investors who specialize in drug stocks are always trying to pull profits from trades based on the three-step FDA "phalanx" that up-and-coming biotechs must navigate to finally get a new drug to market.
But if you really want to cash in, commercialization is the "triggering event" that can make that happen.
And that's exactly where Insys is right now.
Cash In on the Legal Weed Derivative That's Changing the War on Pain
Bill is a big fan of this biotech, which focuses on the big problem of chronic pain. It's a company that's looking at this malady in new ways.
He's also showing you how to find more stocks like this one – companies that are establishing whole new paradigms in biotechnology, life sciences, and pharmaceuticals.
And there's an entirely new area of focus in pain treatment right now - legal weed...
Top Marijuana Stocks to Watch This Week (March 13)
The top marijuana stocks are skyrocketing because of increased sales in cannabis.
That's why each week, we provide Money Morning readers with marijuana industry news that could move pot stock prices.
A List of the Most Heavily Shorted Stocks in 2017
The markets are at an all-time high, leaving many investors wondering how to profit from a potential market pullback.
Shorting stocks is one of the best strategies to use in a market pullback. This strategy allows you to sell high and buy low and markets drop.
We compiled a list of the most heavily shorted stocks to help you profit in 2017...
Why the Top Medical Marijuana Stocks Are Climbing
The top medical marijuana stocks are climbing after Election Day 2016 turned out to be a defining moment for the marijuana industry.
Without question, this is just the start of the gains for these marijuana stocks.